Biogen Idec: After Earnings Miss, Pipeline Success Key

Anyone hoping that Biogen Idec’s (BIIB) earning would send shares shooting back towards it’s 52-week high were surely disappointed by the biotech giant’s financial results this morning. Boston Globe via Getty Images Reuters has the details on Biogen Idec’s earnings: [Biogen Idec] said it expected 2014 earnings, excluding items, of $11.35 to $11.45 per share, compared [...]